ProQR Receives Rare Pediatric Disease Designation from FDA for Sepofarsen for the Treatment of LCA10
Go back to ProQR Receives Rare Pediatric Disease Designation from FDA for Sepofarsen for the Treatment of LCA10| (NASDAQ: PRQR) | Delayed: 1.88 -0.01 (0.53%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.89 | 52 Week High | $13.33 | |||
| Open | $1.89 | 52 Week Low | $3.48 | |||
| Day High | $1.98 | P/E | N/A | |||
| Day Low | $1.87 | EPS | $0.00 | |||
| Volume | 616,713 | |||||
